Roche Holding AG RHHVF
472.49 USD -15.01 (-3.08%)
As ofNov 17, 2026, 3:57 PM EST
472.49 Day range 480.00
357.30 52-week range 499.76
- YTD
- +14.43%
- 1 year
- +30.57%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
4.68 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 2
- P/B 1
Valuation
P/E 20.2×
P/S 4.2×
P/B 7.7×
P/FCF 18.5×
EV/EBITDA 12.8×
EV/Sales 4.7×
FCF Yield 5.4%
Profitability
Gross Margin 72.9%
Operating Margin 26.6%
Net Margin 20.9%
ROE 38.1%
ROIC 17.2%
ROA 12.8%
Growth (YoY)
Revenue -1.4%
Operating Income 22.0%
EPS (diluted) 55.5%
Free Cash Flow -6.6%
Financial Health
Current Ratio 1.4×
Quick Ratio 1.1×
Debt / Equity 1.0×
Net Debt / EBITDA 1.3×
Interest Coverage 12.1×
Dividends
Dividend Yield 3.2%
Payout Ratio 65.1%
Annual · latest fiscal year ends 2025-12-31
